Patent Assignment
Reel/Frame 055556/0832
Change of Name
Recorded: 2021-03-10
Pages: 2
Assignor
HEMOGENYX LLC
Executed: 2020-08-10
Assignee
HEMOGENYX PHARMACEUTICALS LLC
760 PARKSIDE AVENUE, BROOKLYN, NEW YORK, 11226
Covered Properties
(2)
Method of Eliminating Hematopoietic Stem Cells/Hematopoietic Progenitors (Hsc/Hp) in a Patient Using Bi-Specific Antibodies
Monoclonal Antibodies to Human FLT3/FLK2 Receptor Protein
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.